Contact lens-associated microbial keratitis poses a diagnostic dilemma for optometrists on two fronts. The distinction between sterile inflammation and microbial infection is often blurred. In addition, there is a requirement with nearly 50 per cent of the Australian and New Zealand optometric profession being therapeutically endorsed, to distinguish between cases of infection that can be managed in the community verses those that require escalation to public hospitals that have access to laboratory diagnostic tools and advanced imaging techniques, such as in vivo confocal microscopy. Pattern recognition and incorporation of knowledge of aetiology and risk factors assists optometrists to decide on optimal management strategies. Skilled optometrists will utilise emerging diagnostic and therapeutic technologies to ensure safe management strategies and better outcomes for these cases.
EPIDEMIOLOGY
The incidence of contact lens (CL)-related microbial keratitis (MK) is reliably established and historically stable at 2-4 per 10,000 wearers per year for daily soft lens wearers and 20 per 10,000 for overnight soft lens wearers. [1] [2] [3] [4] [5] Despite the introduction of silicone hydrogel lens materials that eliminate the hypoxic stress to the cornea during overnight wear, 6 there is no decrease in the risk of bacterial keratitis in CL wearers.
Daily disposable lens wear results in less severe infection, presumably due to the reduction in exposure to environmental organisms that are likely to be present in CL cases. However, in the most recent robust population-based surveillance study by Stapleton and colleagues 1 and a hospital-based case control prospective study by Dart and colleagues, 7 a reduction in the rate of infection has not been demonstrated. This is despite a decrease in an umbrella of inflammatory events with daily disposable compared to reusable soft lens wear, from more recent case control studies. 8, 9 The use of rigid lenses on a daily wear schedule still has the lowest incidence of MK of all lens types. 1 Two increasingly utilised modalities are orthokeratology (ortho-K) lenses and cosmetic lenses. Both these lens types are likely to have greater uptake among young wearers, particularly ortho-K with the use as a myopia prevention modality. Concerns include the reshaping process effect on physiology and the possibly more responsive ocular surface of the younger age group. While practitioners mostly monitor ortho-K wearers closely, the issue with cosmetic lenses centres on unregulated supply and lack of education. There are case reports and case series of MK occurring in both modalities, [10] [11] [12] but it is difficult with the small population currently wearing these lens types to obtain a reliable estimate of risk or incidence of disease.
The most reliable estimate of the prevalence of ortho-K MK is a retrospective survey of 89 practitioners across the USA. 13 For 1,317 patients, 640 adults (49 per cent) and 677 children (younger than 18 years of age, 51 per cent), and 2,599 patient years, they found a risk of 13.9 per 10,000 (95 per cent confidence interval [CI] 1.7-50.4) patient years for children and 0 per 10,000 (95 per cent CI 0-31.7) for adults. As MK is rare, this represents only two cases of MK in children and none in adults and as the CIs overlap, there is no definitive proof that risk is higher with children as more children are fitted with ortho-K lenses.
From this retrospective ortho-K survey, six of the eight cases of painful red eye with infiltrates (including the two judged by a review panel to be MK) were in children, suggesting a higher incidence of infiltrative events with younger ages. This overall risk of MK with ortho-K lenses from this estimate is similar to that of overnight lens wear using soft lens types (hydrogel and silicone hydrogel). Given the concern for infection in children, which can impact on learning and result in a high morbidity, a well-designed multisite prospective case control study is warranted.
between 2007 and 2009. 14 Thirty-two (12.5 per cent) of the 256 patients across 12 university hospitals were cosmetic lens wearers. These cosmetic lens wearers were younger and had less lens wear experience compared to other lens wearers in the cohort. It is telling that cosmetic lenses were infrequently dispensed by eye-care professionals and this increased the risk of MK by a factor of 12.3 (odds ratio [OR] , 95 per cent CI 4.8-31.5). In addition, lens care and handling education was lacking for the majority of cosmetic wearers, increasing the risk by 26.5 times (OR, 95 per cent CI 10.0-70.2). A worrying result is that 60 per cent of cosmetic lens wearers with MK versus 13 per cent of other lens types had resultant visual acuity poorer than 6/60.
Around 90 per cent of MK in CL wearers is due to bacteria. 15 While Acanthamoeba and fungi represent small proportions of overall numbers, they are proportionally more severe. 15 There were outbreaks of both Acanthamoeba and Fusarium filamentary fungal keratitis in the mid-2000s related to inadequate disinfection solution use in combination with poor hygiene practices. 16, 17 While the immediate effect of the voluntary withdrawal of two CL disinfecting solutions was an apparent decrease in infections of both Acanthamoeba and Fusarium filamentary fungus, keratitis from both these organisms has been reported to be rising since. It was first highlighted that Acanthamoeba did not return to the base level before the outbreak in the mid-2000s 18 and indeed an increase in more recent years, beginning around 2012, has been reported from several centres not linked to a specific disinfecting solution.
19-21 More recently, an increased level of filamentary fungal CL MK cases has been reported. 22, 23 The cost of CL MK is high both on a personal level and to the health system, and in the short and long term. In bacterial MK, 11-14 per cent of patients lose significant vision (two lines of vision or more). 24 For Acanthamoeba keratitis (AK), 30 per cent lose significant vision 21 and keratoplasty occurs in at least 20 per cent of patients. 21 For filamentary fungal keratitis, the need for keratoplasty is higher, with a British Ophthalmic Surveillance Study between 2003-2005 finding the proportion of keratoplasty at 40 per cent. 25 In this review, we will concentrate on the diagnosis and management of CLassociated MK. As an understanding of the aetiology and pathogenesis of infection is useful to understand the signs and symptoms, and the risk factors may be part of the diagnostic work-up, these areas will also be briefly discussed.
AETIOLOGY
Experimental models of CL bacterial keratitis have shown that to reliably initiate infection, penetration of the corneal epithelium needs to take place in the presence of pathogenic levels of bacteria. 26 The primary vector for transmission of the bacteria is thought to be the CL. 27 This may be mediated through different pathways, including the CL storage case, hands, eyelids, contaminated cosmetic eye products (such as mascara) and contact with contaminated water. 28 A comparison of the types of bacteria colonising CLs compared with potential sources of contamination show that normal ocular microbiota contamination correlates with bacterial species from the lids and Gram-negative bacterial contamination corresponds with those found in the water supply. 29 Studies have shown that wearing goggles while swimming decreases the bacterial populations on CLs, indicating water contact via this route can contaminate CLs. 30, 31 CL case microbiota differ between CL solutions and can vary between the same preservative type, indicating that excipients in the care solution play a role in controlling microbial colonisation of this important reservoir of pathogenic microbes. 32, 33 Ocular surfaces of CL wearers have decreased Gram-positive populations compared to non-lens wearers and greater populations of Gram-negative species. 34, 35 It is important that CL-associated suspected MK treatment and prophylactic antibiotic prescribing provide adequate activity against Gram-negative organisms, in particular Pseudomonas aeruginosa which is the most prevalent pathogen in CL-related MK in most regions. 3, 4, 36, 37 The pathogenesis of Pseudomonas aeruginosa MK has been extensively studied. 38 Within the Pseudomonas family are strains that are internalised into epithelial cells and others that are cytotoxic. 38 Pseudomonas aeruginosa is associated with hotter climates and recently in New York, Pseudomonas aeruginosa keratitis was reported more frequently in the summer months. 39 As Pseudomonas aeruginosa is a water-borne organism, a greater tendency to swim in summer months may also influence this increased risk. 39 Gram-positive bacteria are the most prevalent organisms in CL MK in temperate climates such as Melbourne, Australia 40 and in France. 41 These organisms include coagulase-negative Staphylococcus (including Staphylococcus epidermidis), Staphylococcus aureus and Streptococcus pneumoniae. As coagulase-negative Staphylococcus is found on the lid margins, it is possible that at times this organism is a contaminant; however, it can also cause infection when introduced to a normally sterile site. 42 Other organisms commonly found on the lids include Proprionibacterium and Corynebacterium, which also can rarely cause keratitis. 42 Twenty per cent of individuals carry Staphylococcus aureus and there is a nasomucosal association with recurrent systemic infection. 43 Staphylococcus aureus is associated with more severe disease than coagulase-negative Staphylococcus, as well as recurrent infections. 43 Other bacterial species have been reported but with less frequency. These include: Serratia marcescens, 42 a water-borne Gram-negative organism; Nocardia, a Grampositive bacteria that causes an epithelial slow-progressing granulomatous appearance, that can resemble adenovirus; nontuberculosis Mycobacterium, M. Cheloni and M. Fortutim (although Mycobacterium keratitis is more common after laser in situ keratomileusis). 44, 45 Pseudomonas aeruginosa and Staphylococcus epidermidis are able to adhere to and replicate on CLs in vitro, on both silicone hydrogel and hydrogel materials. 46 In addition, Pseudomonas aeruginosa, Serratia marcescens and Staphylococcus aureus can form biofilms on CLs. 47, 48 These biofilms are more resistant to environmental challenges and some CL solutions. 49 Gram-negative Achromabacter, Stenotrophomonas and Delftia have recently been identified as scaffold organisms in biofilm on CL cases and CLs of keratitis patients. 45 In addition, Elizabethkingia forms biofilms on CL cases. 50 These four organisms have physiology similar to Pseudomonas; however, virulence is lower and antibiotic resistance profiles are different from those of Pseudomonas. 50 The extent to which these organisms contribute to CLassociated MK is yet to be clarified.
Prolonged exposure to debris, toxins and antigens trapped between the CL and the corneal surface is also likely to contribute to the risk of infection, 51 possibly reflected in the lower risk with rigid lenses 4,7,52-54 that have higher post-lens tear exchange compared to soft lenses. In addition, CLs slow epithelial cell proliferation 55 and migration 56 and lower the exfoliation rate, [57] [58] [59] thereby lowering corneal epithelial cell renewal. Bacteria adherent to epithelial cells and/or compromised epithelial cells are therefore retained for longer on the corneal surface and have a greater chance of initiating inflammation.
Epithelial permeability is also increased in CL wear. 60 However, a recent randomised study has found that daily saline rinsing and nudging the lens to move on waking during 30-day continuous wear, to increase tear mixing, did not decrease epithelial permeability and in fact for nonAsian participants, increased the adverse events rate. However, there are some caveats to this study; the saline solution contained boric acid which has been shown to adversely affect epithelial cells and the mechanical pressure of nudging the lens may have disrupted the ocular surface, predisposing to adverse events. 61 
RISK FACTORS
The major risk factors identified in epidemiological studies of CL-associated infective and inflammatory keratitis are shown in Tables 1 and 2 . The two main risk factors are overnight wear and poor hygiene, which account for 43 per cent and 33 per cent of the population-attributable risk of CLassociated MK. 62 In severe keratitis, CL case hygiene (cleaning and replacement) accounts for 63 per cent of the populationattributable risk. In addition, swimming is a risk factor for AK [63] [64] [65] and travel is a risk for severe infection, 40 thought to be related to disruption of routine. The risk of infection in extended wear is higher with increased wearing time 7, 53, 66 and less experience. 1 Wearers considering extended wear should be motivated and aware of this increased risk; however, it is important to balance the risk with other lifestyle risks. Some individuals such as shift workers and those with busy lifestyles may feel the convenience of extended wear outweighs the increased risk.
Males are more prone to complications in CLs, as they are with most other diseases. 79 It is thought this may be due to increased noncompliance and also a reluctance to seek care. 80 Recently, it has been found that genetic differences in CL wearers can affect the susceptibility and severity of keratitis. Small mutations (single nucleotide polymorphisms) of interleukins, inflammatory mediators, and defensin, an antimicrobial peptide, have been isolated as contributory. 74, 75, 81 This may mean some people have a degree of innate protection against infection and inflammation when wearing CLs, but this protection is much lower than the risk of poor hygiene and overnight wear and it is important for all wearers to be vigilant.
While it has been shown that risk-taking personality styles are associated with noncompliance in CL wear, 82 there have been no studies to indicate whether risk-taking is associated with the susceptibility to corneal inflammation and infections. There are likely to be many drivers for noncompliance and not being aware of the risks or understanding the consequences of non-compliance are likely to be key factors with some CL wearers.
DIAGNOSIS Bacterial keratitis
Microbial keratitis is usually accompanied by a robust inflammatory response, which together with replicating microbes and necrotic cells form an irregular focal infiltrate with surrounding diffuse inflammation and/or oedema of the cornea. In bacterial keratitis, it is unusual for a focal epithelial defect (ulcer) to be absent; however, this is not the case for AK. 15 In some cases of steroid use or immuno-incompetent patients, a focal infiltrate can be absent, and an epithelial defect or melting stromal keratitis may be the only signs of infection. 15 Vision is usually affected even if the lesion is not in the central four millimetres of the cornea, due to inflammation of the surrounding cornea, which results in scattered light and photophobia. Bystander effects, such as lid swelling, conjunctival chemosis and anterior chamber reaction are common.
Pseudomonas aeruginosa produces enzymes including protease and elastase, 83 which digest collagen, contributing to corneal melting and perforation. An intense immune response also adds to the destruction. 83 The hallmark signs of Pseudomonas aeruginosa keratitis are corneal oedema and a ring abscess (defined as a circular infiltrate with a less dense centre). In a recent study examining 18 CL culture-proven Pseudomonas aeruginosa infections, half of them exhibited ring abscesses and these cases were more severe despite a similar number of days to diagnosis, indicating virulence of the organism was likely to play a role in the poorer outcomes. 84 In a multivariate analysis, swarming motility of the Pseudomonas aeruginosa was associated with larger lesions, ring abscesses and presence of hypopyon. 84 
Author
Year Reference An example of Pseudomonas aeruginosa keratitis is shown in Figure 1 . In centrally located ulcers, CL wear is associated with cytotoxic (exoU) strains of Pseudomonas aeruginosa; however, a recent analysis showed that the invasive (exoS) non-cytotoxic strain is associated with worse outcome. This may be confounded by other factors such as older age of patients, poor presenting visual acuity and large infiltrates. 85 Analysis of the strains of Pseudomonas aeruginosa from the Steroids for Corneal Ulcer Treatment (SCUT) study that express the exoU gene indicated greater fluoroquinolone (FLQ) and gentamicin resistance compared to strains that do not express this gene. 86 
Acanthamoeba keratitis
Subtle corneal signs with or without symptoms of pain can be found in early AK. 87 The initial signs are an epitheliopathy with or without a dendritic appearance. Infiltrates running along nerves from the periphery (perineural infiltrates [ Figure 2 ]), while sometimes seen in Pseudomonas aeruginosa, 88 are virtually pathologic for AK, occurring in around 60 per cent of cases. 87 Later stages involve central stromal infiltration and in around 20 per cent of cases, immune ring infiltrates. 87 Scleritis, thought to be a sterile inflammatory reaction, tends to occur later in 15-20 per cent of cases. 87 If scleritis develops, often very severe, persistent pain is reported. 87 Differential diagnosis between AK and herpes simplex virus keratitis (HSV-K) can be difficult in the early stages and around 50 per cent of AK cases are misdiagnosed as HSV-K. 89 
Fungal keratitis
Fungi are opportunistic organisms in that they will not infect a healthy cornea. However, once trauma and inoculation have occurred, the fungi proliferate, produce tissue damage and disrupt host defenses. 90 The fungal hyphae and pseudohyphae form large structures that cannot be fully ingested by polymorphonuclear leucocytes and macrophages. 90 Fungi secrete toxins such as proteases that aid tissue destruction and allow the fungi to penetrate deep into the cornea. 90 Activation of resident corneal cells and host inflammatory cells that are attempting to neutralise the invading organisms adds to the tissue destruction. 90 Deep in the cornea, antifungals are less likely to reach the organisms and corneal scraping is less likely to yield a positive result. It is thought that the rapid progression of fungal keratitis in the early phases is due to organism factors, such as a large fungal inoculum and penetration deep into the corneal stroma, while progression in the later phases involves a combination of agent and host factors and resistance to antifungals. 91 The main fungal species that cause keratitis are: the yeast, Candida sp. and the filamentary fungi, Aspergillus sp. and Fusarium sp. CL use and trauma are mainly associated with the filamentary fungi, while ocular surface disease is commonly caused by Candida sp. 91 An example of keratitis caused by filamentary fungus is shown in Figure 3 . Microsporidia is a parasitic fungus that has recently been identified to cause keratoconjunctivitis. It has been found in CL wearers but is usually associated with soil/mud and occurs in immunocompromised patients. 92 
DIFFERENTIAL DIAGNOSIS

Organism type
In a large survey of 300 cases of bacterial MK, including 151 CL-associated cases, Gram-negative bacteria were associated with anterior chamber reaction and large ulcers, thought to be related to greater virulence of Gram-negative compared to Gram-positive bacteria. 94 Large ulcers were predictive of Pseudomonas aeruginosa and ring infiltrates of Acanthamoeba. 94 As this is likely to occur in late stages of AK, this criteria should be used with caution in cases where it is the initial presentation. Ring infiltrates are observed with many severe keratitis cases, including Pseudomonas aeruginosa keratitis. 84 Epitheliopathy, pseudodendrites and stromal inflammation in AK can be easily confused with HSV-K. In a recent audit of nearly 200 cases of AK at Moorfields Eye Hospital, mainly from the period 2000-2012, 50 per cent of AK cases were initially diagnosed as HSV-K. 89 When these cases develop stromal inflammation, they are often placed on topical corticosteroids. In this recent audit, the use of corticosteroids before the initiation of antiamoebic drugs, is independently associated with a four-times increased risk of poorer outcomes. 89 Differential diagnosis of the clinical signs of fungal keratitis from more common bacterial ulcers can be difficult, especially with yeast fungi such as Candida. Yeast infections tend to present as discrete infiltrates and overlying defects, 95 but unlike most bacterial infections, the onset of yeast-like infections tends to be slow.
In a large case series of 228 filamentary fungus keratitis cases and 132 bacterial cases in India, common features of fungal keratitis cases were serrated ulcer margins with raised slough and dry texture infiltrate that was usually white or grey (not yellow) and satellite lesions. 96 However, it is of note that bacterial lesions can also have serrated edges 96 and ophthalmologists were unable to predict fungus as the causative organism in the study by Dahlgren and colleagues. 94 As discussed, immune rings (ring infiltrates/Wesley rings) are not pathognomonic of fungal keratitis 96 and can occur in other severe forms of keratitis, including those caused by Acanthamoeba and bacteria. 87 
Inflammation versus bacterial infection
In the study by Dahlgren and colleagues, 94 15 ophthalmologists were asked to identify sterile compared to culture-proven ulcerative keratitis from 104 cases. Good positive predictability was observed with 79 (76 per cent, 95 per cent CI 67-84) cases correctly classified. 94 A survey of 43 optometrists and final year optometry students at a Cornea and Contact Lens Society of Australia event in Sydney in 2012, revealed 88 per cent thought it was important to determine the distinction between inflammation and infection, yet only 18 per cent felt this was an easy decision. 97 This is likely to be due to the low rate of CL-related infections compared to sterile inflammation seen in optometric practice and the lack of feedback from laboratory tests, as these are generally not done in the community. However, since 2012, the optometric sector has increased dramatically in therapeutic endorsements, with now over 50 per cent of optometrists in Australia having therapeutic rights with access to FLQs. 98 In the eye, as in the skin, the immune system of the body has a limited way to react to foreign stimuli; the consequence is often inflammation. Inflammation occurs due to trauma, allergy and toxic reactions (which includes sterile inflammation due to microbes such as in marginal keratitis and CL peripheral ulcer [CLPU]) as well as infection. 97 Some mechanically induced events such as foreign bodies and mechanically driven corneal insults may be associated with corneal inflammation. [99] [100] [101] The aetiology of these events is typically relatively easy to identify due to the signs of mechanical damage, such as foreign body tracks. Conversely, symptoms associated with these events can range from asymptomatic to foreign bodies and even pain. 102 Other corneal inflammatory events such as infiltrative keratitis driven by microbial products and presumed hypersensitivity reactions typically present with a nonspecific inflammatory response that can be local or generalised. 103 Sometimes these can mimic the immune corneal response seen later in the course of adenoviral keratoconjunctivitis. 104 Careful history of the redness and symptoms as well as the swelling of the lymph glands and the more diffuse, fluffy pattern of the infiltrates that are seen in viral conditions will aid diagnosis. 104 In localised sterile inflammation of the cornea, such as marginal keratitis and CLPU, the redness usually is sectorial corresponding to the corneal lesion; however, in infection there is diffuse and more intense redness. In moderate/severe infection, the redness is deeper and the lid as well as anterior chamber are likely to be involved (the bystander effect). Table 3 , which is based on a scheme proposed by Aasuri and colleagues 105 details the differential signs and symptoms of CLPU compared to MK.
Corticosteroids have been used alone to treat sterile CLPU; 107 however, prophylactic antibiotic coverage may be preferred. Cases of bacterial keratitis, in addition to fungal, acanthamoeba and HSV-K, prescribed corticosteroid alone can result in masking and enhancement of infection. 108 It is interesting to note that Cruzat and colleagues 109 have shown a subclinical inflammatory reaction in the contralateral eye of unilateral keratitis observed with in vivo confocal microscopy (IVCM) observation of reduced nerves, increased presumed inflammatory cells, and a corresponding decrease in corneal sensation compared to a control group of CL and non-CL wearers. A contralateral sympathetic response has also been seen in HSV-K. 110 
Diagnostic techniques
For suspected MK, a 'corneal scrape' is performed to collect samples of the lesion containing the causative organism. The protocol is generally to inoculate specimen collection paraphernalia in the clinic. initial samples, which in the microbiology laboratory will be treated with Gram stain. This will render Gram-positive organisms pink and Gram-negative organisms blue. Organism morphology such as rod or cocci shape, fungal hyphae and Acanthamoeba cysts can also be visualised from the Gram stain. 111 Some laboratories, particularly those in tropical climates such as India, also perform a potassium hydroxide wet mount to look for fungal elements. 112 Other samples from the corneal scrape are taken for culture and molecular testing (polymerase chain reaction [PCR]). PCR samples are generally collected with a sterile swab. For culture, the majority of organisms will grow on blood agar in aerobic conditions; however, generally several additional samples are collected, including: an additional blood agar that will be cultured in anaerobic conditions; chocolate agar which includes nutrients for fastidious organisms; Robinson's cooked meat broth; and Sabouraud dextrose agar plate which includes antibiotics to grow fungus. 42 For Acanthamoeba, a non-nutrient agar plate is inoculated in the clinic with a section of epithelium (which is usually fragile in early AK). 87 In the laboratory the non-nutrient agar is washed with heat-killed Escherichia coli, a food source for Acanthamoeba. The plate is observed under a microscope periodically up to 12 days. Trophozoites appear early, slowly moving through the agar with a contractile motion as they ingest the E. coli. 113 Cysts generally appear after several days to weeks as the food source depletes.
Gram stain results and PCR can be available in a matter of hours, and this can be helpful in severe cases to target therapy. Culture results are available usually from two to seven days. 42 Fungi typically take longer than bacteria to grow. Drug sensitivity testing is performed from the cultured organisms, which is important to guide therapy in non-responsive cases. 42 If antibiotics have been commenced in large or non-responsive cases, usually they will be stopped for 24 hours and diagnostic testing will take place in order to maximise the chance of organism recovery. 15 The scrape, as well as having diagnostic value, also debrides the cornea of necrotic and infected tissue, decreasing the organism load and aiding penetration of topical treatments. 15 Kaye and colleagues 114 have shown in patients and an animal model that a single sample using a blade and placed in liquid culture medium then plated in the laboratory, has recovery equivalent to plating all samples in the clinic. However, this technique may introduce confounding contaminants that on an agar plate are visualised as not associated with the inoculated streak. Kaye and colleagues 115 have also trialled a filter paper technique, which is slightly less reliable; however, it may be a useful tool in areas where it is impractical to inoculate a full array of scraping media.
Repeat scraping and/or corneal biopsy can be useful for recalcitrant cases. 15 The biopsy is deeper than a corneal scrape and can be done with a trephine or freehand. This is particularly useful in fungal keratitis as filamentary fungi may proliferate in the deeper corneal layers, so surface scrapes may not capture the organism. Typically for a biopsy, half the material is sent for microbial culture while the other half is sent to histology for tissue processing. 15 The histological or immunohistopathological analysis 
In vivo confocal microscopy
Some large centres will have the facility of IVCM. Bacteria are too small to visualise on IVCM; however, Acanthamoeba cysts and fungal hyphae can be seen. It has been suggested that this technique is accurate only in the hands of an experienced user 116 as the structures can be easily confused with immune cells, nerve fibres and activated stromal keratocytes. 117 
MANAGEMENT
Bacterial keratitis
Antibiotic topical treatment is the mainstay for most CL MK. For mild to moderate cases of MK, standard therapy is generally empirical, whereby a broad-spectrum FLQ is prescribed. 15 A typical regime might be every 1-2 hours for at least the first 24 hours, then review and over time reducing to four times a day depending on the resolution. 15 In severe disease, some clinicians advise a loading dose of say every 15 minutes for the first hour; however, this needs to be balanced with toxicity to the ocular surface.
The first period is the sterilisation phase where the organism is neutralised, followed by the healing phase. 15 The sterilisation phase usually takes 3-5 days. Often a dilating agent, such as atropine, is used to relax ciliary bodies and prevent ciliary spasm, stabilise the blood-aqueous barrier and prevent the iris from sticking to the lens (forming posterior synechiae). Review is recommended within 24 hours and daily until clear improvement is established. In a few days, the eye can be more inflamed due to an inflammatory response to dead organisms, but it is important that there is not a dramatic deterioration in status. 15 Some centres tend to treat severe MK with fortified antibiotics that are compounded by an accredited pharmacy. The combination is often a cephalosporin for Gram-positive coverage, such as cephazolin and an aminoglycoside for Gram-negative activity, either tobramycin or gentamicin. A randomised controlled clinical trial conducted in Melbourne, Australia 118 revealed that monotherapy with ofloxacin 0.3 per cent and moxifloxacin one per cent has similar efficacy and safety profiles compared to fortified tobramycin 1.33 per cent and cephazolin five per cent antibiotics. A landmark study by Gangopadhyay and colleagues 119 showed epithelial toxicity due to fortified combination. However, this is likely to depend on the dosing regime, with the Melbourne study having a rapid drop in dosage frequency over a week, then replacement with chloramphenicol ointments, not showing toxicity effects. 118 If non-compliance or complications are likely in severe keratitis, patients may be admitted to hospital to be monitored more closely than in the community, although in Australia, the proportion admitted varies between hospitals. 108 Fluoroquinolones were first used as ophthalmic topical chemotherapy in the 1990s. 120 Ophthalmic FLQs include: the second generation, ofloxacin 0.3 per cent and ciprofloxacin 0.3 per cent; third, levofloxacin 0.5 per cent; and fourth, moxifloxacin 0.5 per cent, gatifloxacin 0.5 per cent and besifloxacin 0.6 per cent. Structural changes in the fourth generation FLQs provide them with greater Gram-negative coverage than third generation, while maintaining good coverage against Gram-positives. 120 Organisms are also less likely to become resistant to fourth generation FLQs. 120 In Australia, the second generation FLQs, ciprofloxacin and ofloxacin, are available as commercial products. Compounding pharmacies can manufacture later generation FLQs. Ciprofloxacin has enhanced activity toward Gram-negative organisms 121 and may be a preferred option in CL MK in hot climates and/or when signs indicate a possible Pseudomonas aeruginosa cause. In cooler centres, where Staphylococcus sp. is more likely, ofloxacin may be more suitable. White precipitates in the corneal ulcer can occur with ciprofloxacin, although these do not appear to result in adverse effects. One retrospective study indicated there was an increased risk of perforation with ofloxacin compared to fortified antibiotics; 122 however, a more recent prospective study did not find any increased risk. 118 There is little resistance to ciprofloxacin and ofloxacin in Australia 123 compared to the USA and India, although there is some resistance to cephalothin. 124 Chloramphenicol is a broad-spectrum bacteriostatic agent that has been available in Australia over the counter since 2010. Pseudomonas aeruginosa is intrinsically resistant to chloramphenicol. 125 Chloramphenicol is contraindicated in CL-associated infections due to a high proportion of cases that have Pseudomonas aeruginosa as the causative organism.
Altering treatment for indolent or resistant cases is essential and tends to follow a step-wise approach. 15 In cases with corneal melting, tetracycline such as doxycycline can be administered orally. In addition to antimicrobial actions, tetracyclines inhibit matrix metalloproteinases, thereby limiting the breakdown of collagen. 126 The value of oral antibiotics in MK is limited; however, oral ciprofloxacin is used when lesions are close to the limbus and intraocular spread of infection is of concern. 127 
Acanthamoeba keratitis
Acanthamoeba is a single-celled protozoan that is found mainly in contaminated water and soil, but also in dust and air. 128 It is an extremely resilient organism that exists in two forms: the active trophozoite that moves by contractions of finger-like projections, and the dormant cyst that is encased in a double-layer cellulose wall. While trophozoites are sensitive to many chemotherapeutic agents, cysts are mostly resistant. Biguanides (polyhexidine biguanides, PHMB 0.02-0.06 per cent, and chlorhexidine 0.02-0.2 per cent) and diamidines (propamidine isethiotate 0.1 per cent, Brolene, May and Baker, UK and hexamidine 0.1 per cent, Desomedine, Chauvin, France) are the most effective cystocidal agents. 129 None of the treatments are licensed but there is good evidence from case series that they are effective in vivo. 87 A Cochrane review 130 found only one randomised controlled trial 131 comparing chlorhexidine and PHMB 0.02 per cent and the sample size (56 eyes) was insufficient to determine a clinical meaningful difference between the agents. Some resistant strains have been reported for the diamidines, 132 although diamidines are used widely in combination therapy.
Fungal keratitis
Fungal keratitis is often highly invasive and antifungal agents tend to be fungistatic which can lead to a prolonged treatment and often surgical intervention. 133 The polyene, natamycin, is most commonly the initial agent of choice. The Mycotic Ulcer Treatment Trial Phase 1 (MUTT I) has shown natamycin to be more effective than the azole (voriconazole) for filamentary fungus, such as Fusarium and Aspergillus, 134 the most common agents in trauma and CLrelated disease. 133 In deep fungal ulcers and scleritis, oral voraconazole can be also prescribed and patients need to have baseline and monitored liver function tests and commonly suffer from visual disturbances. 135 MUTT II recently demonstrated that the addition of oral voriconazole to topical natamycin does not improve outcomes. 136 Although this study, as with MUTT I, enrolled only filamentous fungal smearpositive cases and was well controlled, it was conducted mainly in India, had few CL wearers and included only severe cases, most of whom contracted the condition during agricultural trauma. Resultant differences in filamentary fungal strains, host immune and environmental factors between cases in India and Western countries may mean there is limited generalisability of these studies.
Chlorhexidine, an antiseptic used commonly in AK, 87 has been well tolerated in two randomised controlled trials 137, 138 and can be used as an alternative to natamycin. For yeast infections, such as Candida, which is most common in ocular surface disease and immunosuppressed patients, topical amphotericin B is recommended. 133 Echinocandins (such as caspofugin and micafugin) can be added. 133 There is some evidence that FLQs may be synergistic with amphotericin. 139 Often multiple agents are used to offer maximum coverage. 133 The role of topical corticosteroids in management of keratitis Topical steroids are used in management of bacterial keratitis in many cases to limit the scarring as a lot of the damage occurs in keratitis due to the inflammatory response. They also decrease pain and may improve quality of life. A typical regime would introduce steroids on day three after two days of intense antibiotic therapy. The schedule of steroids, concurrent with antibiotics, might be four times per day for one week, twice a day for one week and once a day for one week, then cease. Tapering steroids is essential to avoid a rebound effect.
A large randomised controlled trial mainly conducted in India (SCUT) found no difference in adverse events between steroid (prednisolone phosphate one per cent) and a placebo (sterile saline) used in conjunction, and started 48 hours after moxifloxacin therapy, highlighting the safety of corticosteroids used in this manner. 140 There was no difference in visual acuity between the steroid and placebo group at three months; however, there was an effect at 12 months, when the Nocardia (a virulent Gram-positive organism which is very rare in Australia) subgroup was excluded. 141 Also at the three-month time point, a subgroup analysis of the more severe ulcers indicated better visual outcomes when steroids were used. 140 Analysis of the Pseudomonas cases from SCUT indicated larger ulcers; however, they responded better to adjunctive steroids than cases due to other bacterial pathogens. There was no benefit in visual acuity compared to the placebo but as with the main analysis, there was no difference in adverse events, indicating a good safety profile. 142 Further subgroup analysis showed a benefit in starting the steroids 2-3 days after antibiotic therapy was commenced compared to four days. 143 Three smaller trials [144] [145] [146] were underpowered to show a difference between steroid and placebo. A Cochrane review 147 was unable to combine data for these smaller studies with the larger SCUT trial as outcome measures were different among the trials. It is interesting that although there was no statistical difference between quality of life in the one trial that measures this outcome, 145 there was a numerical difference. One might hypothesise that a shorter period of poor vision and faster return to daily activities may improve quality of life in the short term, if not improve long-term vision and quality of life. The main concerns for using topical corticosteroids in bacterial keratitis are delayed re-epithelialisation, recurrent infection and increased risk of perforation. 148 These concerns largely stem from observational studies where the conclusions are clouded by the fact that more serious infections are more likely to be given steroids. Increased risk of perforation and recurring infections were not features of the more robust large randomised controlled SCUT trial. The pilot SCUT trial did show a delay in re-epithelialisation 144 but the much larger study did not, indicating this is not likely to be of concern.
The most common complications of long-term topical corticosteroids are an increase in intraocular pressure (IOP) and cataract. However, as the steroids are not used for a long period, these effects are extremely unlikely. In the SCUT trial, none of the 466 patients had IOP over 35 mmHg and a greater number of patients in the placebo compared to the steroid arm had a rise over 25 mmHg but less than 35 mmHg (10 versus two, which was statistically significant). Despite this, baseline and monitoring IOP measurements and crystalline lens inspection should be undertaken. If there is an increase in IOP, this can be managed by tapering the drops and/or adding an IOP-lowering drop. Crystalline lens changes represent a change in lens metabolism and are not reversible.
While steroids are contraindicated prior to antiamoebic treatment, their safety following diagnosis has recently been established in AK. 149 A survey of prescribing trends in the USA showed that 70 per cent of ophthalmologists use topical corticosteroids in the treatment of AK. 150 It is recommended that steroids are not used until there have been at least two weeks of antiamoebic treatment and should not be used without concurrent antiamoebics. 87 Corticosteroids induce fungal growth by suppressing ocular immune mechanisms by inhibiting chemotaxis and ingestion by phagocytes, blocking degranulation, and reducing the production of phagocytes. 151 Topical steroid should not be used during the treatment of a fungal infection. It has been suggested that topical cyclosporine A may be synergistic to fungal therapy as it inhibits filamentary fungal growth. 152, 153 While there is one case series of three 
Therapeutic penetrating keratoplasty
In cases of severe and/or deep corneal infection, therapeutic penetrating keratoplasty can be considered in order to limit the spread of the pathogen to other parts of the eye. This is particularly relevant in filamentary fungal cases. This is not without risk as pathogens may enter the anterior chamber during surgery. 154 Furthermore, corticosteroids used to limit graft rejection may exacerbate the growth of fungus that may remain in the eye following surgery. 154 In AK, therapeutic keratoplasty is limited to impending or perforated corneas, as recurrence often occurs and outcomes are far better following optical keratoplasty in a quiet eye to restore vision. 155 
THE FUTURE IN DIAGNOSIS AND MANAGEMENT OF CL MK Diagnosis
As imaging techniques become more sophisticated and available, the use of instruments such as IVCM are likely to become more precise and beneficial. 156 While IVCM is currently used mainly as a research tool and in large centres, there is scope for this technology, as we have seen with optical coherence tomography, to move into everyday practice. However, the resolution is insufficient to resolve bacteria.
'Lab on a chip' tears film diagnostic tests such as the Rapid Pathogen Screening Adeno Detector (Rapid Pathogen Screening Inc., Sarasota, Florida, USA) 157 are likely to increase in use. An interesting concept is the use of gold nanostars to identify ocular pathogens as a point of care diagnostic. 158 
Treatment CROSSLINKING
Corneal crosslinking is an ultraviolet A light treatment using a photosensitising dye, riboflavin. This procedure, which is used to strengthen stromal bonds in keratoconus, 159 has also been used on a limited scale for severe keratitis cases. In severe keratitis, even when the microbe has come under control, enzymatic degradation of collagen and proteolysis can still occur, leading to corneal melting. 159 It is thought that this treatment in keratitis, as well as a precaution against perforation, may excite free radicals that cause oxidising damage to microbes. 160 It is important to bear in mind that the procedure itself can lead to infections, as epithelial debridement prior to riboflavin application removes the protective barrier to microbial invasion. 133 Ultraviolet exposure can also cause herpes simplex reactivation. 133 Nevertheless, while definite evidence is not available at this stage, it is a promising technology, especially for medical failure cases.
EMERGING OCULAR DRUG DELIVERY MECHANISMS
There are three main issues with the ocular surface and conventional topical drug availability:
1. bioavailability and drug penetration 2. patient compliance and 3. drug and preservative toxicity.
A technique to increase bioavailability and penetration of topical formulations is to encapsulate and/or modify the drug. Examples of this are microsphere and nanoparticle formulations. 161, 162 Contact lenses and collagen shields as drug delivery devices for MK seem logical as CLs are frequently used to bandage a non-healing ocular surface. In conventional CL materials, drugs are released over a short period of time, which can lead to toxicity of the ocular surface and only temporary bioavailability. 163 Techniques to delay the rapid drug release and sustain prolonged treatment include molecular imprinting 164 and nanoparticle embedded drugs. 165 
Host-pathogen interactions
It has been shown that if wearers had small mutations, single nucleotide polymorphisms, in some of the defence and inflammatory genes of molecules at the ocular surface, they were more prone to infection and more severe outcomes. [75] [76] [77] In addition, genetic profiling of pathogens is enabling better understanding of changing antibiotic resistance and virulence factors. 86 In the future, greater knowledge of how the pathogen interacts with the host may enable a tailored individual approach to limit the severity of MK in CL wearers.
CONCLUSION
The majority of CL-related MK is caused by bacteria and the mainstay of treatment is intensive antibacterial therapy to sterilise the cornea. While bacterial species vary with location and climate, Pseudomonas aeruginosa is a likely cause, especially in large lesions with intense infiltration and oedema. Although Acanthamoeba and fungal keratitis are reportedly increasing, the proportion of cases compared to bacterial keratitis is low. A dendritic epitheliopathy in a CL wearer could indicate AK and fluffy non-responsive ulcers could have a fungal cause. It is imperative that these cases are rapidly escalated to corneal specialists in ophthalmology clinics.
With the majority of optometrists in Australia and New Zealand therapeutically licensed, treatment of sterile inflammation and mild MK can be managed in the community; however, central and large ulcers should be referred for diagnostic scraping for the best chance of successful treatment. Caution should be exercised with corticosteroids as they have detrimental effects in AK (prior to antiamoebic treatment), fungal keratitis (at any stage), HSV epithelial keratitis and bacterial keratitis (until corneal scraping and identification of causative organism and antibiotic sensitivities are confirmed, or there is clinical improvement with treatment).
Contact lens practitioners play a crucial role in the management and education of healthy CL wearers. Knowledge of the latest evidence-based information on risk factors, signs and symptoms, emerging causative pathogen trends and treatment regimes, is essential. The ability to work cooperatively with the hospital system will allow cost-and time-effective management of the majority of CL complications in the community, while observing the timely escalation of more severe cases to specialist services.
